FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stella Dolci

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
P Francis; John Crown; Angelo Di Leo; Marc Buyse; Ana Balil; Michael Andersson; Bo Nordenskjöld; Istvan Lang; Raimund Jakesz; Daniel Vorobiof; Jorge Gutiérrez; Guy Van Hazel; Stella Dolci; Sophie Jamin; Belguendouz Bendahmane; Richard D Gelber; Aron Goldhirsch; Monica Castiglione-Gertsch; Martine Piccart-Gebhart
Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.
Fatima Cardoso; Marianne Paesmans; Denis Larsimont; Virginie Durbecq; Chantal Bernard-Marty; Ghizlane Rouas; Stella Dolci; Christos Sotiriou; Martine J Piccart; Angelo Di Leo
Potential predictive value of Bcl-2 for response to tamoxifen in the adjuvant setting of node-positive breast cancer.
Antonio Fabiano Ferreira Filho; John Crown; Fatima Cardoso; Jean-Marie Nogaret; Karen Duffy; Stella Dolci; Susan Rowan; Niall O'Higgins; Veronique Batter; Marianne Paesmans; Martine J Piccart; Angelo Di Leo
3-year results of docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer: a pilot study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stella Dolci (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: P Francis; John Crown; Angelo Di Leo; Marc Buyse; Ana Balil; Michael Andersson; Bo Nordenskjöld; Istvan Lang; Raimund Jakesz; Daniel Vorobiof; Jorge Gutiérrez; Guy Van Hazel; Stella Dolci; Sophie Jamin; Belguendouz Bendahmane; Richard D Gelber; Aron Goldhirsch; Monica Castiglione-Gertsch; Martine Piccart-Gebhart
Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.
Journal of the National Cancer Institute 2008;100(2):121-33.
2004: Fatima Cardoso; Marianne Paesmans; Denis Larsimont; Virginie Durbecq; Chantal Bernard-Marty; Ghizlane Rouas; Stella Dolci; Christos Sotiriou; Martine J Piccart; Angelo Di Leo
Potential predictive value of Bcl-2 for response to tamoxifen in the adjuvant setting of node-positive breast cancer.
Clinical breast cancer 2004;5(5):364-9.
2002: Antonio Fabiano Ferreira Filho; John Crown; Fatima Cardoso; Jean-Marie Nogaret; Karen Duffy; Stella Dolci; Susan Rowan; Niall O'Higgins; Veronique Batter; Marianne Paesmans; Martine J Piccart; Angelo Di Leo
3-year results of docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer: a pilot study.
Anticancer research 2002;22(4):2471-6.
2002: Angelo Di Leo; David Gancberg; Denis Larsimont; Minna Tanner; Tero Jarvinen; Ghizlane Rouas; Stella Dolci; Jean-Yves Leroy; Marianne Paesmans; Jorma Isola; Martine J Piccart
HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1107-16.
2002: Antonio Fabiano Ferreira Filho; Angelo Di Leo; Marianne Paesmans; Marc Beauduin; Anita Vindevoghel; J Michel; Christian Focan; Ahmad Awada; Fatima Cardoso; Stella Dolci; S Bartholomeus; Martine J Piccart
The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutions.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(3):416-21.
2001: Angelo Di Leo; Denis Larsimont; David Gancberg; T Jarvinen; Marc Beauduin; Anita Vindevoghel; J Michel; Christian Focan; F Ries; P H Gobert; MT Closon-Dejardin; Stella Dolci; Ghizlane Rouas; Marianne Paesmans; Jean-Pierre Lobelle; Jorma Isola; Martine J Piccart
HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(8):1081-9.
2001: Martine J Piccart; Angelo Di Leo; Marc Beauduin; Anita Vindevoghel; J Michel; Christian Focan; A Tagnon; F Ries; P Gobert; C Finet; MT Closon-Dejardin; J P Dufrane; Joseph Kerger; F Liebens; S Beauvois; S Bartholomeus; Stella Dolci; Jean-Pierre Lobelle; Marianne Paesmans; Jean-Marie Nogaret
Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(12):3103-10.
2001: Fatima Cardoso; Angelo Di Leo; Denis Larsimont; David Gancberg; Ghizlane Rouas; Stella Dolci; F Ferreira; Marianne Paesmans; Martine Piccart
Evaluation of HER2, p53, bcl-2, topoisomerase II-alpha, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(5):615-20.
2001: Fatima Cardoso; Antonio Fabiano Ferreira Filho; John Crown; Stella Dolci; Marianne Paesmans; A Riva; Angelo Di Leo; Martine J Piccart
Doxorubicin followed by docetaxel versus docetaxel followed by doxorubicin in the adjuvant treatment of node positive breast cancer: results of a feasibility study.
Anticancer research 2001;21(1B):789-95.
2000: Angelo Di Leo; John Crown; Jean-Marie Nogaret; K Duffy; S Bartholomeus; Stella Dolci; S Rowan; N O'Higgins; Marianne Paesmans; Denis Larsimont; A Riva; Martine J Piccart
A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(2):169-75.